Overview

Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation

Status:
Completed
Trial end date:
2021-08-23
Target enrollment:
Participant gender:
Summary
This study was designed to compare 3 immunosuppression regimens: sirolimus and tacrolimus versus everolimus and tacrolimus versus mycophenolate and tacrolimus. The primary outcome is the incidence of cytomegalovirus infection / disease, a relevant medical need in the absence of pharmacological prophylaxis.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital do Rim e Hipertensão
Treatments:
Everolimus
Mycophenolic Acid
Sirolimus
Tacrolimus